HDL Cholesterol
7
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
57%
4 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)
Identifying HDL Composition and Function in Preeclamptic and Normal Pregnancies
Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc)
Effect of Niaspan on Cholesterol in Men
High-density Lipoprotein (HDL) Cholesterol in Women Taking Tibolone
The Low HDL On Six Weeks Statin Therapy (LOW) Study